Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-25 @ 4:57 AM
NCT ID:
NCT01021618
Eligibility Criteria:
Inclusion Criteria:
* Males and non-pregnant, non-nursing females clinically referred for vasodilator stress myocardial perfusion imaging with the addition of exercise
* Age \>=30 years
Exclusion Criteria:
* Extremely limited functional capacity
* Age \<30 years
* Unable or unwilling to provide informed consent
* Pregnant or nursing females
* Current use of methylxanthines within 12 hours of testing
* Current use of dipyridamole or aminophylline within 48 hours of testing
* Uncontrolled hypertension (\>200 mmHg systolic/\>120 mmHg diastolic)
* Known hypertrophic cardiomyopathy with obstruction or severe aortic stenosis
* Decompensated congestive heart failure
* History of sick sinus syndrome or \> first degree atrioventricular block in the absence of a functioning pacemaker
* Asthma or other bronchospastic reactive airway disease
* History of percutaneous coronary intervention or coronary artery bypass grafting, or documented history of acute myocardial infarction or unstable angina within one week of testing
* Patients at risk for hypotensive reaction to regadenoson
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT01021618
Study Brief:
Protocol Section:
NCT01021618